Latest Insider Transactions at Senseonics Holdings, Inc. (SENS)
This section provides a real-time view of insider transactions for Senseonics Holdings, Inc. (SENS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Senseonics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Senseonics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2022
|
Nick B. Tressler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
165,854
+30.37%
|
-
|
|
Jan 03
2022
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+0.76%
|
$18,180
$2.75 P/Share
|
|
Jan 03
2022
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
3,511
+0.89%
|
$7,022
$2.75 P/Share
|
|
Jan 03
2022
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
5,136
+1.25%
|
$10,272
$2.75 P/Share
|
|
Jan 03
2022
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
3,409
+1.12%
|
$6,818
$2.75 P/Share
|
|
Dec 08
2021
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct |
72,115
+50.0%
|
-
|
|
Dec 06
2021
|
Anthony R. Raab |
SELL
Open market or private sale
|
Direct |
136,538
-38.62%
|
$273,076
$2.53 P/Share
|
|
Nov 16
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100,000
-5.44%
|
$300,000
$3.7 P/Share
|
|
Nov 16
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,998
-1.92%
|
$62,994
$3.7 P/Share
|
|
Nov 15
2021
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115,138
-5.89%
|
$345,414
$3.8 P/Share
|
|
Nov 15
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,531
-4.82%
|
$166,593
$3.8 P/Share
|
|
Nov 15
2021
|
Nick B. Tressler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,850
-3.53%
|
$23,550
$3.8 P/Share
|
|
Nov 15
2021
|
Mirasol Panlilio VP Global Sales and Marketing |
SELL
Payment of exercise price or tax liability
|
Direct |
47,851
-4.66%
|
$143,553
$3.8 P/Share
|
|
Nov 15
2021
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
46,426
-4.03%
|
$139,278
$3.8 P/Share
|
|
Nov 15
2021
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
297,995
-6.17%
|
$893,985
$3.8 P/Share
|
|
Oct 01
2021
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
2,717
+0.9%
|
$8,151
$3.45 P/Share
|
|
Oct 01
2021
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
4,094
+1.01%
|
$12,282
$3.45 P/Share
|
|
Oct 01
2021
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
2,798
+0.72%
|
$8,394
$3.45 P/Share
|
|
Oct 01
2021
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
7,246
+0.61%
|
$21,738
$3.45 P/Share
|
|
Aug 25
2021
|
Douglas A Roeder |
SELL
Open market or private sale
|
Direct |
215,747
-78.1%
|
$647,241
$3.5 P/Share
|
|
Aug 25
2021
|
Douglas A Roeder |
BUY
Exercise of conversion of derivative security
|
Direct |
215,747
+32.22%
|
$215,747
$1.66 P/Share
|
|
Aug 24
2021
|
Douglas A Roeder |
SELL
Open market or private sale
|
Direct |
125,342
-67.45%
|
$376,026
$3.65 P/Share
|
|
Jul 01
2021
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
2,758
+0.71%
|
$8,274
$3.5 P/Share
|
|
Jul 01
2021
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
4,035
+1.0%
|
$12,105
$3.5 P/Share
|
|
Jul 01
2021
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
2,678
+0.9%
|
$8,034
$3.5 P/Share
|
|
Jul 01
2021
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
7,142
+0.6%
|
$21,426
$3.5 P/Share
|
|
Jun 15
2021
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
66,449
-1.36%
|
$199,347
$3.69 P/Share
|
|
Jun 15
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,499
-0.99%
|
$34,497
$3.69 P/Share
|
|
Jun 15
2021
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
10,899
-0.94%
|
$32,697
$3.69 P/Share
|
|
Jun 15
2021
|
Mirasol Panlilio VP Global Sales and Marketing |
SELL
Payment of exercise price or tax liability
|
Direct |
8,602
-0.83%
|
$25,806
$3.69 P/Share
|
|
Jun 15
2021
|
Nick B. Tressler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,850
-3.48%
|
$23,550
$3.69 P/Share
|
|
Jun 15
2021
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,212
-1.03%
|
$60,636
$3.69 P/Share
|
|
Jun 14
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-2.47%
|
$200,000
$4.36 P/Share
|
|
Jun 14
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+2.41%
|
$0
$0.54 P/Share
|
|
Jun 14
2021
|
Timothy T Goodnow President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,928
+0.57%
|
$27,928
$1.79 P/Share
|
|
Jun 11
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,628
-5.59%
|
$250,512
$4.0 P/Share
|
|
Jun 11
2021
|
Francine Kaufman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,916
+1.83%
|
$62,748
$3.07 P/Share
|
|
Jun 10
2021
|
Timothy T Goodnow President and CEO |
SELL
Open market or private sale
|
Direct |
380,710
-7.31%
|
$1,142,130
$3.6 P/Share
|
|
Jun 10
2021
|
Timothy T Goodnow President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
380,710
+6.81%
|
$0
$0.54 P/Share
|
|
Jun 10
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,866
-0.95%
|
$56,598
$3.51 P/Share
|
|
Jun 10
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,866
+0.94%
|
$0
$0.54 P/Share
|
|
Jun 09
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,134
-0.31%
|
$18,402
$3.5 P/Share
|
|
Jun 09
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,134
+0.31%
|
$0
$0.54 P/Share
|
|
Jun 04
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.25%
|
$50,000
$2.7 P/Share
|
|
Jun 04
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.24%
|
$0
$0.54 P/Share
|
|
Jun 04
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,627
-5.39%
|
$187,881
$3.0 P/Share
|
|
May 27
2021
|
Stephen P De Falco |
SELL
Open market or private sale
|
Direct |
104,927
-8.23%
|
$209,854
$2.0 P/Share
|
|
May 26
2021
|
Stephen P De Falco |
SELL
Open market or private sale
|
Direct |
4,304
-0.34%
|
$8,608
$2.0 P/Share
|
|
May 25
2021
|
Anthony R. Raab |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+14.61%
|
-
|
|
May 25
2021
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+24.56%
|
-
|